Syntropic Medical

Syntropic is developing a non-invasive, wearable device for the treatment of depression. By activating the immune cells of the brain with light delivered through the eyes, Syntropic can achieve faster and longer relief from symptoms and eliminate adverse drug reactions. 1 in 3 patients with Major Depressive Disorder receive no clinical benefit from standard antidepressant medication and 1 in 4 will discontinue treatment due to adverse drug reactions. This is roughly 3 million patients in the US being failed by the current standard of care. For these 3 million patients and the millions more worldwide, Syntropic is developing an entirely new treatment option, one which utilizes an entirely new mechanism of action in the field of depression treatment.